Latest News and Events
Filter by
Selections
September 24, 2018
Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics
Read MoreSeptember 21, 2018
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Read MoreSeptember 6, 2018
Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit
Read MoreAugust 31, 2018
Arrowhead Completes Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Read MoreAugust 30, 2018
Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences
Read MoreJune 29, 2018